Rethinking clinical trial design for rare tumors
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
There is a movement to reassess the design of clinical trials for rare tumors. The current approach to clinical trials may not be effective for these types of tumors, prompting a reevaluation. A new approach to clinical trial design for rare tumors is being considered.